CA
WST icon

Capitolis Advisors’s West Pharmaceutical WST Stock Holding History

Capitolis Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,821
Closed -$2.73M – 501
2021
Q4 		$2.73M Buy
+5,821
New +$2.51M 0.02% 378
2021
Q2 		– Sell
-2,552
Closed -$719K – 478
2021
Q1 		$719K Sell
2,552
-1,750
-41% -$501K 0.01% 327
2020
Q4 		$1.22M Buy
+4,302
New +$1.21M 0.02% 371

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Capitolis Advisors's WST Position: Q1 2022 in Review

Capitolis Advisors sold out of West Pharmaceutical (WST) in Q1 2022, closing a stake of 5,821 shares — an estimated $2.73M sold.

Capitolis Advisors first reported a position in WST in Q4 2020 and held it in 3 quarters. The position peaked at $2.73M in Q4 2021. 716 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • Capitolis Advisors reported no remaining West Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 5,821 West Pharmaceutical shares in Q1 2022, an estimated $2.73M.
  • Capitolis Advisors first reported a position in West Pharmaceutical in Q4 2020 and held it in 3 quarters.
  • Capitolis Advisors's West Pharmaceutical position peaked at $2.73M in Q4 2021.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.